As GLP-1 frenzy grips India, firms race to build businesses around the weight-loss drug boom - Moneycontrol.com

As GLP-1 frenzy grips India, firms race to build businesses around the weight-loss drug boom  Moneycontrol.comSemaglutide generics regain momentum in July — but few brands lead the charge  ET PharmaGLP-1 agonist market rebounds in July, reaches Rs 2,215 crore MAT sales: Sheetal Sapale  BioSpectrum IndiaQuality in GLP-1 medicines: Why It matters for long-term diabetes care  expresshealthcare.inConference on Diabetes organized by HELP foundation tomorrow  Get Bengal